BioCentury | Mar 19, 2020
Product Development

Roivant pivots towards ARDS in COVID-19; plus Italian studies of repurposed anti-inflammatories, vaccine updates and more

...the pretreatment pool to be dosed if they become infected by SARS-CoV-2. According to ClinicalTrials.gov, Pulmotect Inc....
BioCentury | Oct 1, 2019
Company News

Management tracks: Vertex taps Bozic as CMO; plus Nektar, Sangamo, Ascletis, Neurocrine, Neovacs, Dyne, Avidity, Pulmotect, Adaptimmune and 4BIO

...board. She was president and a board member Akcea Therapeutics Inc. (NASDAQ:AKCA). Respiratory disease company Pulmotect Inc....
BioCentury | Nov 1, 2012
Strategy

Mess with Texas

...trials 10.3 Kalon Biotherapeutics LLC Formation of the Texas Cancer Therapeutics Process Development Lab 7.9 Pulmotect Inc....
BioCentury | Apr 26, 2012
Strategy

Texas translation

...round: RNA diagnostics company Asuragen Inc. , biomanufacturing company Kalon Biotherapeutics LLC and immunomodulator play Pulmotect Inc....
...mAb and a plasmid-based gene therapy. The company did not disclose further details. Asuragen and Pulmotect...
...U.K. Kalon Biotherapeutics LLC , College Station, Texas Houston-Area Translational Research Consortium , Houston, Texas Pulmotect Inc....
BioCentury | Mar 31, 2012
Company News

CPRIT awards $81.3M for cancer research

...biotech grants included $7.9 million to Kalon Biotherapeutics LLC (College Station, Texas); $7.1 million to Pulmotect Inc....
Items per page:
1 - 5 of 5
BioCentury | Mar 19, 2020
Product Development

Roivant pivots towards ARDS in COVID-19; plus Italian studies of repurposed anti-inflammatories, vaccine updates and more

...the pretreatment pool to be dosed if they become infected by SARS-CoV-2. According to ClinicalTrials.gov, Pulmotect Inc....
BioCentury | Oct 1, 2019
Company News

Management tracks: Vertex taps Bozic as CMO; plus Nektar, Sangamo, Ascletis, Neurocrine, Neovacs, Dyne, Avidity, Pulmotect, Adaptimmune and 4BIO

...board. She was president and a board member Akcea Therapeutics Inc. (NASDAQ:AKCA). Respiratory disease company Pulmotect Inc....
BioCentury | Nov 1, 2012
Strategy

Mess with Texas

...trials 10.3 Kalon Biotherapeutics LLC Formation of the Texas Cancer Therapeutics Process Development Lab 7.9 Pulmotect Inc....
BioCentury | Apr 26, 2012
Strategy

Texas translation

...round: RNA diagnostics company Asuragen Inc. , biomanufacturing company Kalon Biotherapeutics LLC and immunomodulator play Pulmotect Inc....
...mAb and a plasmid-based gene therapy. The company did not disclose further details. Asuragen and Pulmotect...
...U.K. Kalon Biotherapeutics LLC , College Station, Texas Houston-Area Translational Research Consortium , Houston, Texas Pulmotect Inc....
BioCentury | Mar 31, 2012
Company News

CPRIT awards $81.3M for cancer research

...biotech grants included $7.9 million to Kalon Biotherapeutics LLC (College Station, Texas); $7.1 million to Pulmotect Inc....
Items per page:
1 - 5 of 5